Cargando…
Melanoma Vaccines and Modulation of the Immune System in the Clinical Setting: Building from New Realities
To endow the immune system with the capacity to fight cancer has always attracted attention, although the clinical results obtained have been until recently disappointing. Cutaneous melanoma is a highly immunogenic tumor; therefore most of the attempts to produce cancer vaccines have been addressed...
Autores principales: | Madorsky-Rowdo, Florencia Paula, Lacreu, María Laura, Mordoh, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343264/ https://www.ncbi.nlm.nih.gov/pubmed/22566975 http://dx.doi.org/10.3389/fimmu.2012.00103 |
Ejemplares similares
-
Immunotherapy in Cancer: A Combat between Tumors and the Immune System; You Win Some, You Lose Some
por: Madorsky Rowdo, Florencia Paula, et al.
Publicado: (2015) -
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2017) -
Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long-term BRAF inhibition
por: Rowdo, Florencia Paula Madorsky, et al.
Publicado: (2020) -
An Update of Cutaneous Melanoma Patients Treated in Adjuvancy With the Allogeneic Melanoma Vaccine VACCIMEL and Presentation of a Selected Case Report With In-Transit Metastases
por: Mordoh, Ana, et al.
Publicado: (2022) -
Early Events of the Reaction Elicited by CSF-470 Melanoma Vaccine Plus Adjuvants: An In Vitro Analysis of Immune Recruitment and Cytokine Release
por: Pampena, María B., et al.
Publicado: (2017)